Pharma Journalist - Page 40 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

FDA Grants Orphan Drug Status to Ajax’s AJ1-11095 for Myelofibrosis

Lilly Invests $6 Billion in Alabama Facility for Next-Generation Medicines

FDA Approves Amneal’s Epinephrine Vials for Emergency and Hospital Use

Pfizer, YaoPharma Partner on GLP-1 Drug for Weight Management

EU Approves Roche’s Gazyva for Advanced Lupus Nephritis Treatment

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Viatris Sells Biocon Biologics Stake for $815M in Strategic Shift

Stay Ahead in RNAi: Join 80+ Leaders Shaping 2026 Innovation

FDA Grants Breakthrough Status to Ionis’ Drug for Alexander Disease

FDA Expands Approval of Lilly’s Jaypirca for Earlier CLL/SLL Treatment